menu
Your Cart

ITT1130

ITT1130
  • Catalog: ITT1130
  • Gene/Protein: CHPF2
  • Product Description: Immunotag™ CSGlcA-T Polyclonal Antibody
385.0000
Price in reward points: 385

Available Options

Immunotag™ CSGlcA-T Polyclonal Antibody
Antibody Specification
Datasheet
Target Protein CSGlcA-T
Clonality Polyclonal
Storage/Stability -20°C/1 year
Application WB,IHC-p,ELISA
Recommended Dilution Western Blot: 1/500 - 1/2000. Immunohistochemistry: 1/100 - 1/300. ELISA: 1/40000. Not yet tested in other applications.
Concentration 1 mg/ml
Reactive Species Human
Host Species Rabbit
Immunogen The antiserum was produced against synthesized peptide derived from human CSGLCAT. AA range:31-80
Specificity CSGlcA-T Polyclonal Antibody detects endogenous levels of CSGlcA-T protein.
Purification The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen
Form Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Gene Name CHPF2
Accession No. Q9P2E5
Alternate Names CHPF2; CHSY3; CSGLCAT; KIAA1402; Chondroitin sulfate glucuronyltransferase; CSGlcA-T; Chondroitin glucuronyltransferase; Chondroitin polymerizing factor 2; ChPF-2; Chondroitin synthase 3; ChSy-3; N-acetylgalactosaminyl-proteoglycan 3-beta-g
Description CHPF2 (Chondroitin Polymerizing Factor 2) is a Protein Coding gene. Among its related pathways are Defective B3GAT3 causes JDSSDHD and Metabolism. GO annotations related to this gene include transferase activity, transferring glycosyl groups and N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity. An important paralog of this gene is B4GALNT4.
Cell Pathway/ Category Chondroitin sulfate biosynthesis,
Subcellular Localization Golgi membrane,membrane,integral component of membrane,Golgi cisterna membrane,
Usage For Research Use Only! Not for diagnostic or therapeutic procedures.
Material Safety Data Sheet
English_US
Danish
Dutch
English_UK
French
German
Spanish
Norwegian
Portuguese
Finnish
Swedish
Polish

Write a review

Note: HTML is not translated!
Bad Good
Captcha

CONNECT WITH US